By Sola Ogundipe
A government panel of experts in India is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India.
India is currently administering AstraZeneca’s COVID-19 vaccine, which is manufactured by the Serum Institute and branded Covishield, and a shot developed by Bharat Biotech called COVAXIN.
According to Reuters, he review comes after Europe’s drug regulator, the European Medicines Agency, EMA, it found a possible link between AstraZeneca’s vaccine and rare blood clotting…
